Evaluation of the effectiveness of valproic acid for treating cyanotic breath holding spells: a pilot prospective study.
CONCLUSION: VPA therapy reduces CBHS' frequency. Mood improvement is a suggestive effective mechanism.
CLINICAL TRIAL REGISTRATION: www.clinicaltrials.gov identifier is NCT04482764.
PMID: 32969724 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
More News: Anxiety | Brain | Cardiology | Children | Clinical Trials | Drugs & Pharmacology | Heart | Iron | Neurology | Study